Business Daily.
.
A+ R A-

Compugen to Present at Upcoming Immuno-Oncology and Rheumatology Conferences

E-mail Print PDF
TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that aspects of its immuno-oncology programs and its lead autoimmune program will be presented at four upcoming scientific conferences.

imageimage

Read more

Grow Your Business with Times Media
Business Daily Media